Abbott recently announced that it agreed to acquire Exact Sciences for approximately $21 billion to enter the fast-growing cancer diagnostic segment. Under the terms of the agreement, Abbott will acquire...

Some Medtech companies recently addressed the potential impact of global tariffs in their Q1 2025 earnings calls.  Johnson & Johnson and Abbott were among the first to speak on the...

A recent paper published by market.us projects that the Deep Brain Stimulation (DBS) devices market is expected to reach around $3.5 Billion by 2033, compared to the projected $1.5 Billion...